Clinical trial
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
NCT01733004 is registered in ClinicalTrials.gov with Merrimack Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
- Lead sponsor
- Merrimack Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- Not reported
- Enrollment
- 42 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma